B2DB — Who said what, where, and when

Mark Coles

Professor of Immunology, University of Oxford

Mark Coles is Professor of Immunology at the Kennedy Institute of Rheumatology, affiliated faculty in the Wolfson Centre for Mathematical Biology, and a member of the MRC Centre of Excellence in Exposome Immunology at the University of Oxford. He is co-founder of Mestag Therapeutics and Lightox Ltd. Research in his group focuses on the application of human experimental medicine to immune-mediated inflammatory disease.

Events Mark Coles has spoken at